LADENBURG THALMANN FINANCIAL SERVICES INC. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 65 filers reported holding ARCUS BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q4 2019$8,000
+14.3%
7900.0%0.00%
Q3 2019$7,000
+16.7%
7900.0%0.00%
Q2 2019$6,000
-40.0%
7900.0%0.00%
Q1 2019$10,000
+11.1%
7900.0%0.00%
Q4 2018$9,000
-18.2%
7900.0%0.00%
Q3 2018$11,000
-8.3%
7900.0%0.00%
Q2 2018$12,0000.0%7900.0%0.00%
Q1 2018$12,0007900.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders